These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19807296)

  • 1. Evidence-based assessment of the efficacy of esomeprazole for the healing of erosive esophagitis.
    Johnson DA
    Expert Rev Pharmacoecon Outcomes Res; 2004 Aug; 4(4):371-82. PubMed ID: 19807296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic evaluation of gastro-esophageal reflux disease.
    Armstrong D
    Yale J Biol Med; 1999; 72(2-3):93-100. PubMed ID: 10780570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux disease: clinical manifestations.
    Williams JL
    Gastroenterol Nurs; 2003; 26(5):195-200. PubMed ID: 14603078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
    Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
    Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy.
    Collen MJ; Abdulian JD; Chen YK
    Am J Gastroenterol; 1995 Jul; 90(7):1053-7. PubMed ID: 7611195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of gastroesophageal reflux disease.
    Heidelbaugh JJ; Nostrant TT; Kim C; Van Harrison R
    Am Fam Physician; 2003 Oct; 68(7):1311-8. PubMed ID: 14567485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Barrett's esophagus after endoscopic healing of erosive esophagitis.
    Hanna S; Rastogi A; Weston AP; Totta F; Schmitz R; Mathur S; McGregor D; Cherian R; Sharma P
    Am J Gastroenterol; 2006 Jul; 101(7):1416-20. PubMed ID: 16863541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of Barrett's esophagus.
    Clark GW; DeMeester TR
    Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease and Barrett's esophagus.
    Falk GW
    Endoscopy; 2001 Feb; 33(2):109-18. PubMed ID: 11272213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic reflections on proton pump inhibitor therapy for non-erosive reflux disease.
    Moayyedi P
    Digestion; 2008; 78 Suppl 1():61-9. PubMed ID: 18832842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and management of gastroesophageal reflux disease.
    Rohof WO; Hirsch DP; Boeckxstaens GE
    Minerva Gastroenterol Dietol; 2009 Sep; 55(3):289-300. PubMed ID: 19829285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonerosive reflux disease.
    Long JD; Orlando RC
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
    Fennerty MB; Johnson DA
    MedGenMed; 2006 Apr; 8(2):6. PubMed ID: 16926745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
    Jankowski J; Hopwood D; Pringle R; Wormsley KG
    Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.